Clinical Oncology
Volume 21, Issue 5 , Pages 401-407, June 2009

Volumetric Modulated Arc Therapy and Conventional Intensity-modulated Radiotherapy for Simultaneous Maximal Intraprostatic Boost: a Planning Comparison Study

  • R. Shaffer

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
    • Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK
    • Corresponding Author InformationAuthor for correspondence: R. Shaffer, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6. Tel: +604-877-6000; Fax: +604-877-0505.
  • ,
  • W.J. Morris

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • V. Moiseenko

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • M. Welsh

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • C. Crumley

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • S. Nakano

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • M. Schmuland

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • T. Pickles

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6
  • ,
  • K. Otto

      Affiliations

    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 4E6

Received 10 October 2008; received in revised form 30 December 2008; accepted 22 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(09)00045-4

doi:10.1016/j.clon.2009.01.014

Clinical Oncology
Volume 21, Issue 5 , Pages 401-407, June 2009